Skip to main content
. Author manuscript; available in PMC: 2019 Sep 1.
Published in final edited form as: J Neurooncol. 2018 May 31;139(3):651–659. doi: 10.1007/s11060-018-2910-9

Figure 4. Overall survival by log-rank test based on the median change in ADC between pre- and post-chemoradiation time points.

Figure 4

Results suggest patients with large, positive changes in ADC have higher OS compared to stable or decreasing ADC changes (HR = 2.931, p = 0.027, Log-Rank).